I’m still baffled that cxo and Ltr are being put in one sentence by many asx investors @DaisyA
your logic is compelling I wish went to the law school with you
shorters being burned in PLS imo ($460 million exposure prior to pls 4C release)
theyd face a huge dilemma in Ltr, I don’t know how much they’ve covered, at one point they’ve covered instantly but that was before when Ltr has 8,000 and not 33,000 shareholders many of which are likely increasing their holding as 25,000-28,000 of these didn’t get the benefit of buying their shares at 2 or 3 cents like the first 5,000 shareholders in 2019.
TG and TO will continue to progress LTr at full steam so their window is narrowing by the day
Id expect pLs will be $25 billion in 12 months as they pile up another $5 billion cash less Capex and divvies
Ltr will be instantly neck and neck with pls when ramped up, which implies a $22 billion upside once’s ramped up
the time between the need for the remaining funding and DSO and/or commissioning will likely be less than 6 months.
Ltr may have to conclude it sooner in getting the right offers from a range of sources still being considered even if they won’t need the money until end of 2023.
LG or tesla could very well be the financiers for at least some, and EFA. Id discount another equity raise given the huge interest that has not abated
Ltr remains to have the best risk reward value proposition in my view.
all imo
- Forums
- ASX - By Stock
- LTR
- LTR: Short squeeze coming for shorters - 2nd highest likelihood in all ASX
LTR: Short squeeze coming for shorters - 2nd highest likelihood in all ASX, page-122
-
- There are more pages in this discussion • 4,002 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.030(3.00%) |
Mkt cap ! $2.352B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 96.5¢ | $13.68M | 13.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 76446 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 54268 | 0.965 |
16 | 448006 | 0.960 |
10 | 273881 | 0.955 |
34 | 357765 | 0.950 |
7 | 148508 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 50000 | 1 |
0.980 | 30256 | 2 |
0.985 | 5873 | 2 |
0.990 | 28958 | 4 |
0.995 | 8676 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online